akhatri

The Commission on Human Medicines (CHM) has endorsed changes to the risk minimisation measures for isotretinoin, following a review of the impact of the measures implemented in 2023. We ask healthcare professionals to review these new measures and supporting materials and integrate them into their clinical practice. Second prescriber no longer required plus updated risk [...]

The post MHRA Drug Safety Update: Isotretinoin – changes to prescribing guidance and additional risk minimisation measures appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has confirmed that the Serious Shortage Protocols (SSP) for Adipine® XL 30mg MR tablets (SSP084) and Adipine® XL 60mg MR tablets (SPP085) will expire at 23:59pm Friday 23rd January 2026. SSP 084 and SSP085 were originally set to expire on 6th February 2026 however, the expiry has been [...]

The post Expiry of SSP084 Adipine® XL 30mg MR tablets and SSP085 Adipine® XL 60mg MR tablets appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Recall: Paliperidone Mercury Pharma prolonged-release suspension for injection in pre-filled syringes Drug alert number: EL(26)A/01 Date issued: 20 January 2026 Mercury Pharmaceuticals Ltd is recalling remaining stock of paliperidone pre-filled syringes as a precautionary measure due to Good Manufacturing Practice (GMP) deficiencies cited during a recent inspection at the finished product [...]

The post MHRA Class 2 Medicines Recall: Paliperidone Mercury Pharma prolonged-release suspension for injection in pre-filled syringes appeared first on Community Pharmacy England.

Pharmacy teams should be aware that all strengths of Subutex® and Suboxone® tablets have been discontinued. The manufacturer, Indivior, is no longer supplying these products in the UK therefore, they are no longer available for community pharmacies to order. Please note that if a prescriber has issued a branded prescription for any strength of Subutex®, [...]

The post Discontinuation of Subutex® and Suboxone® tablets appeared first on Community Pharmacy England.

The MHRA has reviewed the warnings regarding addiction, dependence, withdrawal, and tolerance for gabapentin, pregabalin, benzodiazepines, and z-drugs. The findings (detailed in the Public Assessment Report) were that it was necessary to strengthen these warnings in the product information and on packaging to better inform healthcare professionals and patients of these known risks. Advice for [...]

The post MHRA Drug Safety Update: Improving Information Supplied with Gabapentinoids (Pregabalin/Gabapentin), Benzodiazepines and Z-Drugs appeared first on Community Pharmacy England.